Seung-Hwan Lee1, Kyongae Sung, Kyong-Sang Lee, Eunok Moon, Chang-Gyu Kim. 1. Department of Psychiatry, Inje University, Ilsan-Paik Hospital, 2240 Daehwa-dong, Ilsanseo-gu, Goyang, Republic of Korea; Clinical Emotion and Cognition Research Laboratory, 2240 Daehwa-dong, Ilsanseo-gu, Goyang, Republic of Korea. Electronic address: lshpss@paik.ac.kr.
Abstract
OBJECTIVES: Mismatch negativity (MMN) is known to be associated with neurocognition, social cognition, and functional outcomes. The present study explored the relationships of MMN with neurocognition, theory of mind, and functional outcomes in patients with schizophrenia, first-degree relatives of patients with schizophrenia, and healthy controls. METHODS: Twenty-five patients with schizophrenia, 21 first-degree relatives of patients with schizophrenia, and 29 healthy controls were recruited. We examined symptom severity, neurocognition, theory of mind, functional outcomes, and MMN. RESULTS: MMN amplitudes decreased in order of patients with schizophrenia, then first-degree relatives, then healthy controls. MMN amplitude was significantly correlated with measures of neurocognition, theory of mind, and functional outcome measurements in patients with schizophrenia. However, the most powerful correlations were those between MMN in the frontal region and measures of functional outcomes. The power and frequency of the correlations were weaker in first-degree relatives and healthy controls than in patients with schizophrenia. Hierarchical regression analysis revealed that functional outcomes (relative to measures of neurocognition and theory of mind) constituted the most powerful predictor of MMN. CONCLUSIONS: Our results suggest that MMN reflects functional outcomes more efficiently than do measures of neurocognition and theory of mind in patients with schizophrenia.
OBJECTIVES: Mismatch negativity (MMN) is known to be associated with neurocognition, social cognition, and functional outcomes. The present study explored the relationships of MMN with neurocognition, theory of mind, and functional outcomes in patients with schizophrenia, first-degree relatives of patients with schizophrenia, and healthy controls. METHODS: Twenty-five patients with schizophrenia, 21 first-degree relatives of patients with schizophrenia, and 29 healthy controls were recruited. We examined symptom severity, neurocognition, theory of mind, functional outcomes, and MMN. RESULTS: MMN amplitudes decreased in order of patients with schizophrenia, then first-degree relatives, then healthy controls. MMN amplitude was significantly correlated with measures of neurocognition, theory of mind, and functional outcome measurements in patients with schizophrenia. However, the most powerful correlations were those between MMN in the frontal region and measures of functional outcomes. The power and frequency of the correlations were weaker in first-degree relatives and healthy controls than in patients with schizophrenia. Hierarchical regression analysis revealed that functional outcomes (relative to measures of neurocognition and theory of mind) constituted the most powerful predictor of MMN. CONCLUSIONS: Our results suggest that MMN reflects functional outcomes more efficiently than do measures of neurocognition and theory of mind in patients with schizophrenia.
Keywords:
ANOVA; BACS; Brief Assessment of Cognition in Schizophrenia; EEG; EOG; Functional outcome; GAF; Global Assessment of Functioning; K-SAS; Korean version of the Social Adjustment Scale; MMN; Mismatch negativity; Neurocognition; PANSS; Positive and Negative Syndrome Scale; SFQ; Schizophrenia; Social Functioning Questionnaire; TMT-A & B; Theory of mind; ToM; Trail Making Test-A & -B; analysis of variance; electroencephalogram; electrooculograms; mismatch negativity; theory of mind
Authors: Ricardo E Carrión; Barbara A Cornblatt; Danielle McLaughlin; Jeremy Chang; Andrea M Auther; Ruth H Olsen; Daniel C Javitt Journal: Schizophr Res Date: 2015-02-23 Impact factor: 4.939
Authors: William C Hochberger; Yash B Joshi; Michael L Thomas; Wendy Zhang; Andrew W Bismark; Emily B H Treichler; Melissa Tarasenko; John Nungaray; Joyce Sprock; Lauren Cardoso; Neal Swerdlow; Gregory A Light Journal: Neuropsychopharmacology Date: 2018-10-30 Impact factor: 7.853
Authors: W C Hochberger; Y B Joshi; W Zhang; M L Thomas; D L Braff; N R Swerdlow; G A Light Journal: Int J Psychophysiol Date: 2018-12-23 Impact factor: 2.997
Authors: Michael Avissar; Shanghong Xie; Blair Vail; Javier Lopez-Calderon; Yuanjia Wang; Daniel C Javitt Journal: Schizophr Res Date: 2017-07-11 Impact factor: 4.939